Paratek Pharmaceuticals (PRTK) Short Interest Ratio & Short Volume → AI “wealth window” is closing soon! (From Paradigm Press) (Ad) Free PRTK Stock Alerts Notice: This company has been marked as potentially delisted and may not be actively trading. Add Compare Share Share Short InterestStock Analysis Paratek Pharmaceuticals Short Interest DataCurrent Short Volume2,640,000 sharesPrevious Short Volume2,830,000 sharesChange Vs. Previous Month-6.71%Dollar Volume Sold Short$5.83 millionShort Interest Ratio / Days to Cover4.9Last Record DateAugust 31, 2023Outstanding Shares57,320,000 sharesFloat Size43,180,000 sharesShort Percent of Float6.11%Today's Trading Volume4,764,400 sharesAverage Trading Volume724,253 sharesToday's Volume Vs. Average658% Short Selling Paratek Pharmaceuticals ? Sign up to receive the latest short interest report for Paratek Pharmaceuticals and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort InterestDays to CoverShort Percent of FloatPRTK Short Interest Over TimePRTK Days to Cover Over TimePRTK Percentage of Float Shorted Over Time Ad Paradigm PressBitcoin Rockets To Record High But Buy THIS InsteadRecently, Bitcoin smashed through its previous record high to hit $72,720. It’s made many, many people very rich. But one cryptocurrency expert and investing millionaire is declaring…>>Click here to find out what it is. Paratek Pharmaceuticals Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 8/31/20232,640,000 shares $5.83 million -6.7%6.1%4.9 $2.21 8/15/20232,830,000 shares $6.20 million -2.8%6.0%3.3 $2.19 7/31/20232,910,000 shares $6.40 million +0.3%6.4%3.4 $2.20 7/15/20232,900,000 shares $6.38 million +13.7%6.4%3.2 $2.20 6/30/20232,550,000 shares $5.64 million +0.8%5.6%2.8 $2.21 6/15/20232,530,000 shares $5.54 million -42.0%5.6%2.5 $2.19 Get the Latest News and Ratings for PRTK and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Paratek Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. 5/31/20234,360,000 shares $6.67 million -2.0%9.6%3.9 $1.53 5/15/20234,450,000 shares $8.68 million -6.5%9.8%6.2 $1.95 4/30/20234,760,000 shares $7.57 million +3.7%10.8%6.8 $1.59 4/15/20234,590,000 shares $12.48 million +8.3%10.1%7 $2.72 3/31/20234,240,000 shares $10.77 million +17.1%9.2%6.8 $2.54 3/15/20233,620,000 shares $6.91 million +2.0%7.8%7.3 $1.91 2/28/20233,550,000 shares $6.21 million +1.1%7.9%12.3 $1.75 2/15/20233,510,000 shares $7.02 million +0.6%7.8%11.3 $2.00 1/31/20233,490,000 shares $7.57 million -0.6%8.3%9.9 $2.17 1/15/20233,510,000 shares $8.42 million +0.9%8.2%9.3 $2.40 12/30/20223,480,000 shares $6.51 million No Change8.2%9.1 $1.87 12/15/20223,480,000 shares $6.30 million -2.5%8.2%8.8 $1.81 11/30/20223,570,000 shares $7.93 million +7.2%8.4%9.3 $2.22 11/15/20223,330,000 shares $7.16 million +2.5%7.9%8.7 $2.15 10/31/20223,250,000 shares $11.57 million -10.7%7.8%8.5 $3.56 10/15/20223,640,000 shares $12.30 million -19.5%8.9%9.7 $3.38 9/30/20224,520,000 shares $11.62 million +6.4%11.0%12.7 $2.57 9/15/20224,250,000 shares $10.46 million +6.3%10.3%9.2 $2.46 8/31/20224,000,000 shares $10.04 million -0.5%9.8%7.4 $2.51 8/15/20224,020,000 shares $11.74 million -3.6%9.8%7.1 $2.92 7/31/20224,170,000 shares $9.55 million +17.1%10.2%7.1 $2.29 7/15/20223,560,000 shares $8.79 million -12.1%8.7%5.8 $2.47 6/30/20224,050,000 shares $7.82 million -21.7%15.8%5.6 $1.93 6/15/20225,170,000 shares $10.29 million -7.2%20.2%7.1 $1.99 5/31/20225,570,000 shares $10.53 million -5.1%13.8%9.8 $1.89 5/15/20225,870,000 shares $11.86 million +4.8%13.4%10.8 $2.02 4/30/20225,600,000 shares $12.38 million -1.6%13.2%10.5 $2.21 4/15/20225,690,000 shares $14.51 million +5.8%13.5%11.3 $2.55 3/31/20225,380,000 shares $15.98 million +10.3%12.9%12.2 $2.97 3/15/20224,880,000 shares $15.23 million +8.0%11.5%15.1 $3.12 2/28/20224,520,000 shares $15.91 million +6.9%11.1%14.9 $3.52 2/15/20224,230,000 shares $16.92 million +7.6%10.3%13.8 $4.00 1/31/20223,930,000 shares $15.92 million +4.5%9.6%13.3 $4.05 1/15/20223,760,000 shares $16.81 million No Change9.2%13.1 $4.47New crypto project uncovers 2,050% in 65 days (Ad)During the event on Tuesday, April 23 at 10 am ET, I’ll be giving away the name and ticker symbol of crypto that could surge in price. I believe it will be the best performing crypto of 2024.Just click here to sign up and be among the first to get it. PRTK Short Interest - Frequently Asked Questions What is Paratek Pharmaceuticals' current short interest? Short interest is the volume of Paratek Pharmaceuticals shares that have been sold short but have not yet been closed out or covered. As of August 31st, investors have sold 2,640,000 shares of PRTK short. 6.11% of Paratek Pharmaceuticals' shares are currently sold short. Learn More on Paratek Pharmaceuticals' current short interest. What is a good short interest ratio for Paratek Pharmaceuticals? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. PRTK shares currently have a short interest ratio of 5.0. Learn More on Paratek Pharmaceuticals's short interest ratio. What is a good short interest percentage for Paratek Pharmaceuticals? Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 6.11% of Paratek Pharmaceuticals' floating shares are currently sold short. Is Paratek Pharmaceuticals' short interest increasing or decreasing? Paratek Pharmaceuticals saw a decline in short interest in the month of August. As of August 31st, there was short interest totaling 2,640,000 shares, a decline of 6.7% from the previous total of 2,830,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. What is Paratek Pharmaceuticals' float size? Paratek Pharmaceuticals currently has issued a total of 57,320,000 shares. Some of Paratek Pharmaceuticals' outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. Paratek Pharmaceuticals currently has a public float of 43,180,000 shares. How does Paratek Pharmaceuticals' short interest compare to its competitors? 6.11% of Paratek Pharmaceuticals' shares are currently sold short. Here is how the short interest of companies in the sector of "medical" compare to Paratek Pharmaceuticals: Assembly Biosciences, Inc. (1.17%), NGM Biopharmaceuticals, Inc. (4.52%), Kinnate Biopharma Inc. (2.01%), ProQR Therapeutics (0.50%), Hookipa Pharma Inc (0.45%), Theseus Pharmaceuticals, Inc. (2.63%), vTv Therapeutics Inc. (6.11%), BeyondSpring Inc. (9.99%), Kezar Life Sciences, Inc. (4.90%), Immutep Limited (1.43%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: Charter Communications, Inc. ($3.69 billion), Canadian Natural Resources Limited ($3.67 billion), T-Mobile US, Inc. ($3.56 billion), Suncor Energy Inc. ($3.20 billion), Occidental Petroleum Co. ($3.19 billion), Celsius Holdings, Inc. ($2.09 billion), Tractor Supply ($2.08 billion), Moderna, Inc. ($2.04 billion), Royal Caribbean Cruises Ltd. ($2.00 billion), and Rivian Automotive, Inc. ($1.96 billion). View all of the most shorted stocks. What does it mean to sell short Paratek Pharmaceuticals stock? Short selling PRTK is an investing strategy that aims to generate trading profit from Paratek Pharmaceuticals as its price is falling. PRTK shares are trading up $0.04 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Paratek Pharmaceuticals? A short squeeze for Paratek Pharmaceuticals occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of PRTK, which in turn drives the price of the stock up even further. How often is Paratek Pharmaceuticals' short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including PRTK, twice per month. The most recent reporting period available is August, 31 2023. More Short Interest Resources from MarketBeat Related Companies: Assembly Biosciences Short Squeeze NGM Biopharmaceuticals Short Squeeze Kinnate Biopharma Short Squeeze ProQR Therapeutics Short Squeeze Hookipa Pharma Short Squeeze Theseus Pharmaceuticals Short Squeeze vTv Therapeutics Short Squeeze BeyondSpring Short Squeeze Kezar Life Sciences Short Squeeze Immutep Short Squeeze Short Interest Tools: Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:PRTK) was last updated on 4/19/2024 by MarketBeat.com Staff From Our PartnersRed Alert: Your Money's Disappearance Act - Banks' Greed Unleashed!Priority GoldHealthcare Takes A Big Step Forward With The Help Of AIThe Bull ReportThe Best AI Stock to Own in the World Today is Trading for Just $25Banyan Hill PublishingBiden’s $374B Giveaway Into This SectorDTIThe “Perfect Storm” for GoldGold Safe ExchangeForget Bitcoin. Crypto Millionaire Predicts 8,788% Gains For THISParadigm PressHe Is Giving Away BitcoinCrypto Swap ProfitsThe #1 Crypto for 2024InvestorPlace